ro glp-1 supply tracker launches to help patients navigate shortages Ro launches GLP-1 tracker to

Hamilton A, Zhang Q, Salehi A et al (2018) Adrenaline stimulates glucagon secretion by Tpc2-dependent Ca(2+) mobilization from acidic stores in pancreatic alpha-cells

for instance, there is an enhanced propensity for carbohydrate intake in hyperinsulinemic hypoglycemic patients [64]

The MHRA-approved indications for these medications are limited to type 2 diabetes mellitus and, for certain formulations, obesity management in adults with specific BMI thresholds as detailed in their SmPCs

When a user contributes shortage information to the GLP-1 Supply Tracker, Ro gives them the option of automatically reporting that information to the FDA, with no additional steps required

What are GLP-1s

What would you tell someone who is considering this practice